China's WuXi Biologics hits near 3-week peak after shares buyback

WuXi Biologics (Cayman)

12/06/2024 05:06

** Shares of Chinese contract drug research and development
group WuXi Biologics  2269.HK  jump 17.7% to HK$12.92, highest
since May 24
    ** Stock last up 16.2%, on track for biggest one-day pct
rise since November 2022; biggest pct gainer in the Hang Seng
Composite Index  .HSCI  
    ** Co repurchased 1.81 mln shares in open market on Tuesday
at a price between HK$10.98 and HK$11.08 per share for an
aggregate HK$19.92 mln ($2.55 mln), a Hong Kong stock exchange
filing showed  
    ** Hong Kong's healthcare index  .HSCIH  rises 1.2%, while
the Hang Seng Composite Index  .HSCI  falls 1.3% and the Hang
Seng Index  .HSI  drops 1.5%
    ** Stock down 57.2% YTD  
($1 = 7.8088 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))